Amjad Ali Khan Selected Research

Amjad Ali Khan Research Topics

Disease

9	Neoplasms (Cancer) 04/2022 - 04/2020
4	Inflammation (Inflammations) 05/2021 - 01/2018
2	Liver Diseases (Liver Disease) 01/2021 - 02/2019
1	Hemolysis 01/2022
1	Leukopenia 11/2021
1	Bacterial Pneumonia 11/2021
1	Lung Injury 05/2021
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Diabetes Mellitus 02/2021
1	Body Weight (Weight, Body) 02/2021
1	Edema (Dropsy) 01/2021
1	Insulin Resistance 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2020
1	Hypertension (High Blood Pressure) 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Hyperglycemia 01/2018
1	Type 2 Diabetes Mellitus (MODY) 12/2014
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2014
1	Leukemia 08/2008

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 04/2022 - 02/2019
3	thymoquinoneIBA 11/2021 - 02/2019
3	LipidsIBA 05/2021 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 02/2021 - 01/2021
2	gingerolIBA 02/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2021
1	PolyphenolsIBA 04/2022
1	ResveratrolIBA 04/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	Benzo(a)pyreneIBA 05/2021
1	Therapeutic UsesIBA 05/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021
1	Malondialdehyde (Propanedial)IBA 05/2021
1	CarcinogensIBA 05/2021
1	AntioxidantsIBA 03/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021
1	3-hydroxyflavoneIBA 03/2021
1	QuercetinIBA 03/2021
1	Streptozocin (Streptozotocin)FDA Link 02/2021
1	Biological ProductsIBA 01/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	CollagenIBA 01/2021
1	CaspasesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Albumin-Bound Paclitaxel FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	CathepsinsIBA 01/2021
1	NK105IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	Nucleotide AptamersIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	ProdrugsIBA 11/2020
1	TeaIBA 07/2020
1	Catechin (Z 7300)IBA 07/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2020
1	Drug CarriersIBA 04/2020
1	Liposomes (Liposome)IBA 04/2020
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2014
1	Co-Repressor ProteinsIBA 08/2008

Therapy/Procedure

7	Therapeutics 04/2022 - 07/2020
1	Drug Therapy (Chemotherapy) 04/2022
1	Radiotherapy 04/2022
1	Complementary Therapies (Alternative Medicine) 03/2021
1	Oral Administration 01/2021
1	Precision Medicine 01/2021